Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 299

Results For "IMI"

3829 News Found

Biocytogen signs RenMab/RenLite licensing agreement with BeiGene
Biotech | April 26, 2022

Biocytogen signs RenMab/RenLite licensing agreement with BeiGene

In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)


USFDA clears Franklin Mountain Medical's new dual catheter
Biotech | April 26, 2022

USFDA clears Franklin Mountain Medical's new dual catheter

It enables precise visualization and treatment access to the left heart


GSK launches once daily, single inhaler-triple therapy for COPD patients
Drug Approval | April 26, 2022

GSK launches once daily, single inhaler-triple therapy for COPD patients

Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers


Differentiation based on innovation is the way forward: S Aparna
News | April 26, 2022

Differentiation based on innovation is the way forward: S Aparna

Secretary, Department of Pharmaceuticals and Union Health Secretary Chair a Panel Discussion on the theme 'Indian Pharma Vision 2047'


Global AYUSH meet ends with promise of Rs 9000 cr. in investment
News | April 25, 2022

Global AYUSH meet ends with promise of Rs 9000 cr. in investment

Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal


Shionogi’s once-a-day Covid-19 anti-viral shows rapid virus clearance
Biotech | April 25, 2022

Shionogi’s once-a-day Covid-19 anti-viral shows rapid virus clearance

A separate global Phase 3 study of S-217622 is underway aiming to recruit participants globally to support regulatory filings this year


Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya
News | April 25, 2022

Malaria cases and related deaths have reduced significantly: Dr Mansukh Mandaviya

April 25th is commemorated as World Malaria Day


CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment
Drug Approval | April 23, 2022

CHMP recommends EU approval of Roche’s Tecentriq as adjuvant treatment

If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe


Covid-19 vaccine protection against hospitalization wanes
News | April 23, 2022

Covid-19 vaccine protection against hospitalization wanes

Kaiser Permanente finds the Pfizer Covid-19 third dose vaccine protection against hospitalization from omicron wanes after 3 months


We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech
interviews | April 22, 2022

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech

Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans